A detailed history of Pnc Financial Services Group, Inc. transactions in Xencor Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,704 shares of XNCR stock, worth $62,381. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,704
Previous 3,344 19.14%
Holding current value
$62,381
Previous $63,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$15.7 - $21.65 $10,048 - $13,856
-640 Reduced 19.14%
2,704 $54,000
Q2 2024

Aug 09, 2024

BUY
$18.21 - $24.5 $7,975 - $10,731
438 Added 15.07%
3,344 $63,000
Q1 2024

May 10, 2024

SELL
$18.65 - $26.52 $4,289 - $6,099
-230 Reduced 7.33%
2,906 $64,000
Q4 2023

Feb 09, 2024

SELL
$16.53 - $21.42 $14,397 - $18,656
-871 Reduced 21.74%
3,136 $66,000
Q3 2023

Nov 13, 2023

SELL
$20.08 - $25.39 $6,606 - $8,353
-329 Reduced 7.59%
4,007 $80,000
Q2 2023

Aug 11, 2023

SELL
$24.77 - $29.9 $396 - $478
-16 Reduced 0.37%
4,336 $108,000
Q1 2023

May 15, 2023

SELL
$25.95 - $36.95 $4,619 - $6,577
-178 Reduced 3.93%
4,352 $121,000
Q4 2022

Feb 10, 2023

SELL
$24.79 - $30.86 $2,330 - $2,900
-94 Reduced 2.03%
4,530 $117,000
Q3 2022

Nov 10, 2022

BUY
$24.62 - $32.44 $22,108 - $29,131
898 Added 24.1%
4,624 $120,000
Q2 2022

Aug 12, 2022

BUY
$19.74 - $29.01 $58,627 - $86,159
2,970 Added 392.86%
3,726 $101,000
Q1 2022

May 12, 2022

SELL
$26.68 - $41.63 $87,483 - $136,504
-3,279 Reduced 81.26%
756 $20,000
Q4 2021

Feb 11, 2022

BUY
$33.67 - $43.44 $2,760 - $3,562
82 Added 2.07%
4,035 $161,000
Q3 2021

Nov 05, 2021

BUY
$30.65 - $35.68 $42,695 - $49,702
1,393 Added 54.41%
3,953 $129,000
Q2 2021

Aug 06, 2021

SELL
$34.33 - $44.68 $19,877 - $25,869
-579 Reduced 18.45%
2,560 $88,000
Q1 2021

May 07, 2021

BUY
$40.81 - $53.88 $9,835 - $12,985
241 Added 8.32%
3,139 $135,000
Q4 2020

Feb 12, 2021

BUY
$36.63 - $47.63 $3,333 - $4,334
91 Added 3.24%
2,898 $126,000
Q3 2020

Nov 06, 2020

BUY
$30.09 - $43.02 $49,648 - $70,983
1,650 Added 142.61%
2,807 $108,000
Q2 2020

Aug 07, 2020

SELL
$27.76 - $33.42 $12,880 - $15,506
-464 Reduced 28.62%
1,157 $37,000
Q1 2020

May 08, 2020

SELL
$20.69 - $37.79 $32,566 - $59,481
-1,574 Reduced 49.26%
1,621 $48,000
Q4 2019

Feb 07, 2020

SELL
$32.75 - $41.43 $2.84 Million - $3.6 Million
-86,854 Reduced 96.45%
3,195 $109,000
Q3 2019

Nov 08, 2019

BUY
$33.73 - $46.27 $3.04 Million - $4.17 Million
90,049 New
90,049 $3.04 Million
Q4 2017

Feb 09, 2018

SELL
$19.29 - $24.83 $801,287 - $1.03 Million
-41,539 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$19.61 - $23.35 $814,579 - $969,935
41,539
41,539 $0

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.38B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.